LensGen, Inc.

IRVINE, CA · Founded 2011 · Medtech · Private

Curvature-changing fluid lens for presbyopia correction

Claim this profile

Follows are private to you and power your alerts

Updated · lensgen.com

Sector
Medtech
Headquarters
IRVINE, CA
Founded
2011
Latest Form D
$7.3M, May 2017
Total capital
$8.5M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$8.5M
3 Form D · last May 2017
113 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
17
23 pending · first 2015
Rank in peer group#130 of 1112

Capital timeline

20132014201520162017FEDERAL ↑EQUITY ↓Cumulative $8.5M1st Form D$950K2nd Form D$300K3rd Form D$7.3M
20132014201520162017FEDERAL ↑EQUITY ↓Cumulative $8.5M1st Form D$950K2nd Form D$300K3rd Form D$7.3M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$7.3M
  • Private capital raisedForm D · SEC · 2nd filing$300K
  • Private capital raisedForm D · SEC · 1st filing$950K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#130 · top 12%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Akiteru FurukawaDirectorNamed in SEC Form D filings
  • Michael S. ColacoDirectorNamed in SEC Form D filings
  • Ramgopal RaoExecutive Officer, DirectorNamed in SEC Form D filings
  • Shivbir S. GrewalDirectorNamed in SEC Form D filings

What it has protected

USPTO · 17 granted of 40
  • PendingAccommodating Intraocular Lens DeviceUSPTOApplication 19313388
  • GrantedAccommodating Intraocular Lens DeviceUSPTOUS 11,826,246
  • PendingIntraocular Lens Device And Related MethodsUSPTOApplication 18047156
Show all 40 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .